Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2005
10/19/2005CN1223363C Medicinal composition with beauty function and its preparing method
10/19/2005CN1223351C Use of low-molecular-weight heparins for preventing and treating cerebral edemas
10/19/2005CN1223349C Drug combination for treatment of depression and related disorders comprising mirtazapine
10/19/2005CN1223347C Aqueous cilostazol preparation for injection
10/19/2005CN1223343C Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956051 amphiphilic drug-oligomer conjugates comprising a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety; therapeutic agents coupled to amphiphilic oligomers
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005US6955814 protecting and/or preserving organs, in particular the heart during open-heart surgery, cardiovascular diagnosis or therapeutic intervention by administering potassium channel opener or agonist and adenosine receptor agonist and local anesthetic
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2335451C Process and product for promoting weight loss in overweight dogs
10/18/2005CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
10/18/2005CA2295063C Indole compounds as anti-inflammatory/analgesic agents
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2152507C Novel combination of benzoquinazoline antifolates and protecting agents
10/18/2005CA2132544C Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/18/2005CA2046265C Sulphured imadazole derivatives, their preparation process, the new intermediates obtained, their application as drugs and the pharmaceutical preparations containing them
10/13/2005WO2005095621A1 Method of regulating gene introduction with use of artificial magnetic material and system therefor
10/13/2005WO2005095613A1 Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095600A1 Heparin-binding protein having heparan sulfate sugar chain attached thereto, process for producing the same and medicinal composition containing the same
10/13/2005WO2005095419A1 Thiazolopyrimidine derivative
10/13/2005WO2005095416A1 Process for producing flavone c glycoside derivatives
10/13/2005WO2005095414A1 Adiponectin increasing agent
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095373A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095372A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095363A1 Bicyclic compound and medicine containing the same
10/13/2005WO2005095356A1 Agent for generating heat or singlet oxygen and composition for cancer treatment each comprising organic peroxide or chemiluminescent compound
10/13/2005WO2005095341A1 Nitrogen-containing heterocyclic compound
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094890A1 Composition for increasing body height
10/13/2005WO2005094889A1 Remedy or preventive for arthritis
10/13/2005WO2005094886A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
10/13/2005WO2005094885A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain
10/13/2005WO2005094867A1 Anticancer activity enhancer of viral therapy and method of cancer prevention or treatment
10/13/2005WO2005094858A1 Antidiabetic composition
10/13/2005WO2005094856A1 Preparation and therapeutic uses of plants and plant extracts in the hylocereus genus
10/13/2005WO2005094851A1 Water-soluble fraction extracted from animal organ, method of producing the same, reverse transcription inhibitor, reverse transcriptase inhibitor, viral growth inhibitor and medicinal compositions
10/13/2005WO2005094847A1 Process for producing bone marrow cell inducer and production apparatus therefor
10/13/2005WO2005094823A1 Flt-3 INHIBITOR
10/13/2005WO2005094821A1 A medical composition for increasing the medicine safety
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005094795A1 Use of beta2-sympathomimetics for balbuties treatment
10/13/2005US20050228184 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
10/13/2005US20050228180 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228053 Atamestane and toremifene dosage forms and kits for use treating breast cancer
10/13/2005US20050228051 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/13/2005US20050228042 Statin-like compounds
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228033 Voltage-gated sodium channel (VGSC) and prostate voltage sodium channel (PVSC) inhibitors for treating diseases characterized by overabundant or hyperactive VGSC/PVSC's; phenytoin derivatives; use as sodium channel blockers, anti-cancer agents; can be used to limit or prevent PSA growth and metastasis
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228025 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/13/2005US20050228022 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants
10/13/2005US20050228020 Beta secretase inhibitors
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228005 Protein kinase inhibitors and uses thereof
10/13/2005US20050228001 Methods and compositions for treating platelet-related disorders
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227996 Use of creatine or creatine compounds for skin preservation
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227988 compounds capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; gliomas, meningomas, cancers, Hodgkin's disease, retinal vascularization; core structure that comprises a benzazocine moiety
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227984 Drugs for improving the prognosis of brain injury and a method of screening the same
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227978 Fibrosis inhibitor
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227972 treating disorders of the cardiovascular system; adenosine receptor agonists/antagonists
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005US20050227948 Hif hydroxylase inhibitors
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227353 Methods of inducing differentiation of stem cells
10/13/2005US20050227282 Human extracellular matrix-1
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050226926 Sustained-release tablet composition of pramipexole
10/13/2005US20050226871 Using mixture of fk-506 and geldanamycin compound immobilized onto polypeptide; both compounds bind to polypeptide components of steroid receptor complexes, hsp90 and FKBP52, respectively
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226840 Use of creatine or creatine compounds for skin preservation
10/13/2005US20050224372 Multiple compartment bag assembly for dialysis fluid
10/13/2005DE19829844B4 Verwendung von D-Galaktose zur Verhinderung von Nekrosen Use of D-galactose to prevent necrosis
10/13/2005DE10393799T5 Kinaseinhibitoren für die Behandlung von Erkrankungen Kinase inhibitors for the treatment of diseases
10/13/2005CA2563103A1 Enhancer of anticancer activity in viral therapy and method of preventing or treating cancer
10/13/2005CA2562944A1 Adiponectin enhancer
10/13/2005CA2561530A1 Therapeutic or prophylactic agent for arthritis
10/13/2005CA2561401A1 Process for producing flavone c glycoside derivatives
10/13/2005CA2561383A1 Prophylactic and/or therapeutic agents for chronic musculoskeletal pain
10/12/2005EP1584619A1 Derivatives of quinoline as inhibitors for MEK
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583554A2 Use of natriuretic peptides for the treatment of stature disorders related to the shox gene
1 ... 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 ... 1564